| Autism spectrum disorder: classification, diagnosis and therapy SR Sharma, X Gonda, FI Tarazi Pharmacology & therapeutics 190, 91-104, 2018 | 604 | 2018 |
| Comparative postnatal development of dopamine D1, D2 and D4 receptors in rat forebrain FI Tarazi, RJ Baldessarini International Journal of Developmental Neuroscience 18 (1), 29-37, 2000 | 404 | 2000 |
| Effects of newer antipsychotics on extrapyramidal function D Tarsy, RJ Baldessarini, FI Tarazi CNS drugs 16, 23-45, 2002 | 386 | 2002 |
| Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors HO Tayeb, HD Yang, BH Price, FI Tarazi Pharmacology & therapeutics 134 (1), 8-25, 2012 | 325 | 2012 |
| Animal models of attention-deficit hyperactivity disorder E Davids, K Zhang, FI Tarazi, RJ Baldessarini Brain Research Reviews 42 (1), 1-21, 2003 | 302 | 2003 |
| Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi FI Tarazi, EC Tomasini, RJ Baldessarini Neuroscience letters 254 (1), 21-24, 1998 | 230 | 1998 |
| Pharmacotherapy of psychosis and mania RJ Baldessarini, FI Tarazi Goodman and Gilman’s the pharmacological basis of therapeutics 11, 461-500, 2006 | 218 | 2006 |
| Long-term effects of prenatal stress on dopamine and glutamate receptors in adult rat brain MA Berger, VG Barros, MI Sarchi, FI Tarazi, MC Antonelli Neurochemical research 27, 1525-1533, 2002 | 206 | 2002 |
| 3, 4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease DY Hwang, SM Fleming, P Ardayfio, T Moran-Gates, H Kim, FI Tarazi, ... Journal of Neuroscience 25 (8), 2132-2137, 2005 | 203 | 2005 |
| Postnatal Development of Dopamine D1-Like Receptors in Rat Cortical and Striatolimbic Brain Regions: An Autoradiographic Study FI Tarazi, EC Tomasini, RJ Baldessarini Developmental neuroscience 21 (1), 43-49, 1999 | 198 | 1999 |
| Gene–environment interaction in major depression: focus on experience-dependent biological systems N Lopizzo, L Bocchio Chiavetto, N Cattane, G Plazzotta, FI Tarazi, ... Frontiers in psychiatry 6, 132447, 2015 | 185 | 2015 |
| Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-and D4-like receptors FI Tarazi, A Campbell, SK Yeghiayan, RJ Baldessarini Neuroscience 83 (1), 169-176, 1998 | 161 | 1998 |
| Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors FI Tarazi, EC Tomasini, RJ Baldessarini Developmental Brain Research 110 (2), 227-233, 1998 | 159 | 1998 |
| Emerging therapies for Parkinson's disease: from bench to bedside FI Tarazi, ZT Sahli, M Wolny, SA Mousa Pharmacology & therapeutics 144 (2), 123-133, 2014 | 143 | 2014 |
| Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive? HO Tayeb, ED Murray, BH Price, FI Tarazi Expert opinion on biological therapy 13 (7), 1075-1084, 2013 | 137 | 2013 |
| Brain dopamine receptors: a primer on their current status, basic and clinical RJ Baldessarini, FI Tarazi Harvard review of psychiatry 3 (6), 301-325, 1996 | 135 | 1996 |
| Regulation of working memory by dopamine D4 receptor in rats K Zhang, CJ Grady, EM Tsapakis, SL Andersen, FI Tarazi, ... Neuropsychopharmacology 29 (9), 1648-1655, 2004 | 131 | 2004 |
| Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment FI Tarazi, K Zhang, RJ Baldessarini Journal of Pharmacology and Experimental Therapeutics 297 (2), 711-717, 2001 | 131 | 2001 |
| Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment FI Tarazi, WJ Florijn, I Creese Neuroscience 78 (4), 985-996, 1997 | 123 | 1997 |
| Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats E Davids, K Zhang, NS Kula, FI Tarazi, RJ Baldessarini Journal of Pharmacology and Experimental Therapeutics 301 (3), 1097-1102, 2002 | 110 | 2002 |
